• Home
  • TB 500 10mg*10vials

TB 500 10mg*10vials

180.00
TB500, a synthetic analog of Thymosin Beta-4 (Tβ4), promotes tissue repair and regeneration by regulating actin dynamics and stimulating cell migration, proliferation, and differentiation. It accelerates wound healing by enhancing skin closure and collagen deposition while reducing scar formation. In anti-inflammatory and anti-fibrotic applications, TB500 helps alleviate inflammation in conditions such as fatty liver disease and pulmonary fibrosis. Additionally, it supports cardiovascular health by promoting angiogenesis, protecting cardiomyocytes, and improving cardiac function. As a versatile peptide, TB500 offers innovative solutions for various medical conditions, showcasing significant potential in regenerative medicine.
 
The peptide will be provided as lyophilized powder to ensure maximum stability.
        SPECIAL OFFER

          Please select all product options

          Product was out of stock

          share
          Description

          ▎What is TB500?


          TB500, namely the synthetic analog of Thymosin Beta-4 (Tβ4), is a polypeptide with broad biological activities. By regulating the dynamic equilibrium of actin, it promotes cell migration, proliferation, and differentiation, thus playing a crucial role in tissue repair and regeneration.


          TB500 can accelerate the closure of skin wounds, increase collagen deposition, and reduce scar formation. Meanwhile, it alleviates the inflammatory response in diseases such as fatty liver and pulmonary fibrosis. Moreover, after a myocardial infarction, it protects cardiomyocytes, promotes neovascularization, and improves cardiac function.


          In addition, TB500 features high efficiency, multifunctionality, and excellent biocompatibility. It can act directly on the damaged tissues, maximizing the therapeutic effect while reducing systemic exposure.


          As a novel tool in regenerative medicine, TB500 provides new possibilities for the treatment of various diseases. Its potential in cardiovascular repair, neuroprotection, the treatment of eye diseases, and the management of chronic inflammation has made it a research hotspot in the field of regenerative medicine, driving the development of regenerative medicine towards more precise and efficient treatment approaches.


          ▎TB500 Structure


          1-TB500

          Source: PubChem

          Sequence: LKKTETQ

          Molecular Formula: C38H68N10O14

          Molecular Weight: 889.0 g/mol

          CAS Number: 885340-08-9

          PubChem CID: 62707662

          Synonyms: QHK6Z47GTG


          ▎TB500 Research


          What is the research background of TB500?

          TB500 is a small peptide processed from the active site of thymosin β4. Thymosin β4 has the abilities of tissue regeneration, anti-inflammation, and rapid repair, and TB500 has inherited these properties as well. Initially, in the research on thymosin β4, it was found to possess multiple biological activities, playing important roles in aspects such as cell migration, tissue repair, and inflammation regulation. TB500 is the active fragment of thymosin β4. Researchers hope that through the study of TB500, they can gain a deeper understanding of its mechanism of action and explore whether it can be developed into a drug with specific therapeutic purposes.


          In the fields of wound repair and tissue damage caused by chronic diseases, traditional treatment methods have certain limitations. Due to its potential ability in promoting cell migration and tissue repair, TB500 has become a research hotspot, and people expect it to provide new ideas and methods for treating these diseases. For example, in the research of diseases such as myocardial infarction and nerve injury, studies are carried out to explore whether TB500 can promote the repair of damaged tissues and the restoration of their functions.


          Athletes are prone to various injuries during training and competitions, including muscle strains and ligament injuries. TB500 is believed to potentially help accelerate injury repair and improve the recovery speed of sports injuries, so it has attracted attention in the field of sports medicine. Some studies attempt to explore the application potential of TB500 in the rehabilitation of athletes' injuries. However, at the same time, it has also triggered a controversy about whether it may be abused as a doping. With the development of medicine, the demand for new drugs is constantly increasing. As a peptide substance with a unique mechanism of action, TB500 has the potential to be developed into a new type of drug, providing more options for clinical treatment.


          What is the mechanism of action of TB500?

          Promoting tissue regeneration: 

          TB500 is a small peptide processed from the active site of thymosin β4. Thymosin β4 has the ability to promote tissue regeneration, and TB500 has inherited this property. It may promote tissue regeneration in the following ways:


          Activating cell signaling pathways: 

          It may activate certain specific cell signaling pathways to promote cell proliferation and differentiation. For example, it may activate signaling pathways related to cell growth and repair, such as the PI3K/Akt signaling pathway, etc., thereby stimulating cell proliferation and differentiation and promoting tissue regeneration[1].


          Regulating the extracellular matrix: 

          The extracellular matrix plays an important role in tissue regeneration. TB500 may regulate the synthesis and degradation of the extracellular matrix, promoting cell adhesion, migration, and tissue remodeling. For example, it may increase the synthesis of collagen and elastin, improving the structure and function of tissues[1].


          Anti-inflammatory effect: 

          Inflammation is a defensive response of the body to injury and infection, but excessive inflammation can lead to tissue damage. TB500 has an anti-inflammatory effect and can inhibit the production of inflammatory mediators. Inflammatory mediators such as cytokines and chemokines play a key role in the inflammatory response. TB500 may inhibit the production of these inflammatory mediators, thereby reducing the inflammatory response. For example, it may inhibit the production of inflammatory factors such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β)[1].


          Regulating the function of immune cells: 

          Immune cells play an important role in the inflammatory response. TB500 may regulate the function of immune cells, such as regulating the activity of macrophages and lymphocytes, thereby reducing the inflammatory response. For example, it may promote the transformation of macrophages into an anti-inflammatory phenotype and inhibit the activation and proliferation of lymphocytes[1].


          Accelerating cell proliferation and differentiation: 

          By activating cell signaling pathways and regulating the extracellular matrix, TB500 can accelerate cell proliferation and differentiation, promoting the repair of damaged tissues[1].


          Reducing the inflammatory response: 

          The inflammatory response will delay tissue repair, and the anti-inflammatory effect of TB500 can reduce the inflammatory response, creating a favorable environment for tissue repair[1].


          Promoting angiogenesis: 

          Angiogenesis is crucial for tissue repair. TB500 may promote angiogenesis, increasing the blood supply to damaged tissues, providing nutrients and oxygen for cells, and promoting tissue repair[1].

          2

          Regulation of MMP/TIMP on hepatic fibrosis.

          Source:PubMed[3]


          How does TB500 regulate the synthesis and degradation of the extracellular matrix?

          The balance between the synthesis and degradation of the extracellular matrix (ECM) is essential for maintaining the normal structure and function of tissues. TB-500 may affect the synthesis of the extracellular matrix in the following ways:


          Promoting collagen deposition: 

          TB-500 is believed to be able to promote collagen deposition, and collagen is an important component of the extracellular matrix. The specific mechanism of action may involve the regulation of cell signaling pathways involved in collagen synthesis. For example, it may promote the expression of collagen genes by activating certain growth factors or transcription factors, thereby increasing the synthesis of collagen[2].


          Promoting endothelial cell differentiation and angiogenesis: 

          Endothelial cells secrete a variety of extracellular matrix components during the process of blood vessel formation. TB-500 promotes endothelial cell differentiation and angiogenesis in dermal tissues, which may indirectly promote the synthesis of the extracellular matrix. The newly formed blood vessels require the support of the extracellular matrix, which may stimulate cells to synthesize more extracellular matrix components[2].


          Influence on the degradation of the extracellular matrix:

          It may regulate the activities of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs): 

          The degradation of the extracellular matrix is mainly regulated by matrix metalloproteinases and their inhibitors. Although there is currently no direct evidence that TB-500 regulates the activities of MMPs and TIMPs, considering that TB-500 has the effects of promoting cell migration and wound healing, and the processes of cell migration and wound healing are usually accompanied by the remodeling of the extracellular matrix, this may involve the regulation of MMPs and TIMPs. For example, in the study of liver fibrosis, matrix metalloproteinases and their specific inhibitors (i.e., tissue inhibitors of metalloproteinases, TIMPs) play a key role in collagen synthesis and dissolution. By restoring the balance between MMPs and TIMPs, the accumulation of the extracellular matrix can be inhibited, thereby reducing liver fibrosis[3].


          Indirectly regulating the degradation of the extracellular matrix by affecting cell behavior: 

          TB-500 can promote keratinocyte migration. During the process of cell migration, cells need to regulate the degradation of the extracellular matrix to clear the way. This may involve the secretion of certain enzymes or factors by cells to regulate the degradation of the extracellular matrix. For example, in some physiological and pathological processes, cells secrete matrix metalloproteinases to degrade the extracellular matrix for migration[2].


          In what ways does TB500 interact with biomaterials to promote muscle regeneration?


          Release of bioactive molecules: 

          Biomaterials can serve as carriers and act in concert with TB500 to release bioactive molecules, promoting muscle regeneration. For example, some biomaterials can release active substances such as growth factors. These substances work together with TB500 to stimulate the proliferation and differentiation of muscle cells. TB500 itself has the effects of promoting cell migration and angiogenesis. Combined with the active molecules released by biomaterials, it can more effectively promote muscle regeneration[4, 5].


          The role of biomimetic materials: 

          Biomimetic materials mimic the natural structure and function of muscle tissues, providing a suitable microenvironment for TB500. Such biomimetic materials can be better compatible with muscle tissues, promoting the action of TB500 at the damaged site. For example, biomimetic materials with a specific pore structure can provide support for cell growth, and at the same time, allow TB500 to diffuse and function better[4].


          Immunomodulatory effect: 

          Biomaterials can promote muscle regeneration by regulating the immune system, in coordination with TB500. Studies have shown that biomaterials can regulate the polarization of macrophages thereby controlling the immune response and creating a favorable environment for muscle regeneration. TB500 may further enhance this immunomodulatory effect by affecting the activity of immune cells. For example, through the immunomodulation mediated by biomaterials, the polarization of macrophages can be regulated to promote the soft tissue regeneration of the musculoskeletal system, and TB500 may play a synergistic role in this process[5].


          Combination of stem cells and biomaterials: 

          Stem cells play an important role in muscle regeneration. Combining with biomaterials and TB500 can provide a more effective treatment strategy. Many stem cell populations, such as mesenchymal stem cells and adipose-derived stem cells, are involved in muscle regeneration. Biomaterials can provide support and guidance for stem cells, while TB500 can promote the migration, survival, and differentiation of stem cells. The combination of the three can overcome the limitations of using them alone and promote muscle regeneration.


          Promotion of nerve regeneration: 

          Peripheral nerve regeneration also plays a key role in muscle regeneration. Biomaterials can provide structural bridging to promote nerve regeneration, and TB500 may further promote nerve regeneration and muscle function recovery by affecting the gene expression related to neurogenesis. For example, some studies have found that the gene arrays related to neurogenesis are upregulated, suggesting the role of peripheral nerve regeneration in mediating the recovery of muscle force, and biomaterials and TB500 may jointly promote this process[6].


          Application of magnetically responsive biomaterials: 

          New magnetically responsive biomaterials can enhance muscle regeneration by triggering drug and cell delivery. TB500 can be used in combination with such biomaterials to improve the repair effect of damaged muscles. For example, a biphasic iron gel scaffold can be used to deliver cells and growth factors, precisely timing in vivo to enhance functional muscle regeneration during inflammation. TB500 may act synergistically with this biomaterial to further promote muscle regeneration[7].


          Overall, as a small peptide processed from the active site of thymosin β4, TB500 has shown remarkable potential in tissue regeneration, anti-inflammation, and rapid repair. Research has found that it can promote endothelial cell differentiation, angiogenesis, and keratinocyte migration, and may also regulate the synthesis and degradation of the extracellular matrix. In the field of muscle repair, TB500 may bring new hope for the repair of sports injuries by promoting the proliferation and differentiation of muscle stem cells, regulating the inflammatory response, and interacting with biomaterials. TB500 has the potential to become an effective drug for the adjuvant treatment of tissue damage and related diseases.


          About The Author

          The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.


          Scientific Journal Author

          Ye J is a researcher at Zhejiang University and a member of the Orthopedic Regenerative Medicine Group (CORMed). His research areas include engineering, materials science, automation and control systems, business and economics, and mathematical methods in social sciences. Ye J has been involved with various academic institutions and organizations, such as Opt Clearing Corp, CTC Holdings, University of Illinois Chicago, and Dalian Institute of Chemical Physics, CAS. Ye J is listed in the reference of citation [5].


          ▎Relevant Citations


          [1] Rahaman K, Muresan A, Son J, et al. Development of analytical methods for TB-500 and its metabolites by LC-MS/MS[M]. 2022.10.13140/RG.2.2.32176.02564.


          [2] Ho E N M, Kwok W H, Lau M Y, et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography-mass spectrometry[J]. Journal of Chromatography A, 2012,1265:57-69.DOI:10.1016/j.chroma.2012.09.043.


          [3] Shan L, Wang F, Zhai D, et al. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis[J]. Biomedicine & Pharmacotherapy, 2023,161.DOI:10.1016/j.biopha.2023.114472.

          [4] Carleton M M, Sefton M V. Promoting endogenous repair of skeletal muscle using regenerative biomaterials[J]. Journal of Biomedical Materials Research Part A, 2021,109(12):2720-2739.DOI:10.1002/jbm.a.37239.


          [5] Ye J, Xie C, Wang C, et al. Promoting musculoskeletal system soft tissue regeneration by biomaterial-mediated modulation of macrophage polarization[J]. Bioactive Materials, 2021,6(11):4096-4109.DOI:10.1016/j.bioactmat.2021.04.017.


          [6] Roberts K, Kim J T, Huynh T, et al. Transcriptome profiling of a synergistic volumetric muscle loss repair strategy[J]. Bmc Musculoskeletal Disorders, 2023,24(1).DOI:10.1186/s12891-023-06401-1.


          [7] Cezar C A. Magnetically Responsive Biomaterials for Enhanced Skeletal Muscle Regeneration[M]. 2015.https://www.proquest.com/dissertations-theses/magnetically-responsive-biomaterials-enhanced/docview/1761573755/se-2.


          ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  


          The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.